Clinical Trial: CBD Administration Reduces Heroin Cravings

NORML

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. In clinical models, CBD administration has been shown to reduce cravings for tobacco. Investigators at The Mount Sinai Health System in New York City assessed the effect of CBD versus placebo in 42 drug-abstinent participants with a history of heroin use.

Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain

NORML

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Polish investigators conducted a randomized, double-blind placebo-controlled trial assessing the efficacy of twice-daily transdermal CBD administration on 60 patients with TMD over a period of 14 days.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Japanese Officials Approve Epidiolex For Clinical Trials

Cannabis Law Report

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Japanese officials approve Epidiolex for clinical trials.

InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial

Puff Puff Post

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers.

FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials

Otherside Farms

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials.

InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial

Puff Puff Post

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers.

CBD for Brain-Damaged Babies?

Project CBD

The launch of a clinical trial examining the use of CBD in newborns suffering from hypoxic ischemic encephalopathy (brain damage caused by lack of oxygen) means new hope for the million plus babies born each year with this condition

Today’s Answer of the Day

TheAnswerPage

Are any pre-clinical trials or clinical trials evaluating the therapeutic benefits of CBD currently underway?

US Government Approves Increased Production of Marijuana for Clinical Research

NORML

Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research.

Today’s Answer of the Day

TheAnswerPage

Excluding potential drug:drug interactions, what adverse effects of CBD have been noted in clinical trials? In clinical trials evaluating CBD, adverse effects, including diarrhea, somnolence, decreased appetite, change in weight, and increased levels of liver enzymes have been noted.

Brain Awareness Week: CBD and the Brain

Leafwell

Cannabidiol (CBD) is still a big mystery in many ways.

Canadian Researchers Studying Hemp Protein to Treat Hypertension

Leafly

"If the clinical trial shows that hemp can help reduce blood pressure, then other treatment areas will be examined.". The post Canadian Researchers Studying Hemp Protein to Treat Hypertension appeared first on Leafly. Canada Health Science & Tech Hemp research studies

Today’s Answer of the Day

TheAnswerPage

Transporting [marijuana] across states lines may not be lawful under state laws, unless a patient is participating in a clinical trial and has a letter that documents such participation.”

Today’s Answer of the Day

TheAnswerPage

Do the results of randomized clinical trials support those claims? According to reports in the media and statements on various CBD websites, CBD has anti-depressant effects.

Legislation To Produce And Research Cannabis Introduced

NORML

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. The act ends the University of Mississippi’s existing monopoly on the growth of cannabis for clinical research purposes, by requiring the licensing of additional manufacturers.

Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp

NORML

Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado.

Hemp 285

UK: NHS – The Minimalist Approach To Issuing Cannabis Reimbursements

Cannabis Law Report

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data.

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis Law Report

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. The opportunity of virtual clinical trials appears to meet all of these criteria.

Today’s Answer of the Day

TheAnswerPage

What adverse effects of CBD have been noted in clinical trials? In clinical trials evaluating CBD, adverse effects, including diarrhea, somnolence, decreased appetite, and increased levels of liver enzymes have been noted.

Survey: Three Of Four Military Veterans Would Consider Using Medical Cannabis

NORML

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA).

Kristin & Shelby – Fighting Dravet Syndrome

Leafwell

This is how Kristin Wilcox describes the effect a cannabis-infused drug given to her daughter, Shelby Mathews, during a clinical trial on cannabinoids for Dravet Syndrome. “I saw a change almost immediately. I can’t even explain … I can’t even describe it, but it was … It was like a light started coming back into her eyes.”

Not-very-NICE: UK Cannabis Policy and Harm to Patients

CannaTech

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products.

New Study Aims To Learn If Cannabis Can Help Treat Autism

MedicalJane

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. The CBDV compound for the trial is being shipped from the United Kingdom to Dr. Eric Hollander.

EU Parliament Publish Procedure File & Resolution On, “Use of cannabis for medicinal purposes”

Cannabis Law Report

Ensure that safe and controlled cannabis used for medicinal purposes can only be in the form of cannabis-derived products that have gone through clinical trials, regulatory assessment and approval.”. Here are some of the bullets from the resolution.

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research.

DEA 130

GB Sciences Sells Its Louisiana Medical Marijuana Business at a $32 Million Total Valuation

Cannabis Law Report

GB Sciences also will continue to develop its clinical cannabis formulations for which the company has filed numerous patents, progressing the research towards clinical trials and first-in-human pilot studies. LAS VEGAS, Sept.

Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications

NORML

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.”

CBD: Exploring The Therapeutic Effects of Cannabis Without the High

Canna Care Docs

With increased attention and further legalization efforts in the United States, research surrounding the health applications are still in its infancy stages, but documentation and clinical trials continue to flow into the public sphere.

DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington’s Disease Drug Development

Cannabis Law Report

Tim Moynahan the company chairman stated that “Patients in the MMJ International holdings clinical trials will receiv e gelatin capsules containing THC and CBD daily.”.

Why Dr. Sue Sisley Sued the DEA for Stonewalling Cannabis Research

NORML

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US.

DEA 286

Medical Marijuana is Being Used to Treat Dementia With Success

FloridaMarijuana.net

The clinical trials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia. An article published in Psychiatric Times (part of the Modern Medicine Network) titled “Medical Marijuana and Dementia-Associated Agitation: Stirring the Pot” cites “a positive open-label trial of medical cannabis oil, cited by Maust and colleagues, which used a marijuana extract high in THC and low in other marijuana alkaloids.”

iCann Goes Psychedelic With Tel Aviv PsyTech Summit Global Event

Cannabis Law Report

PsychedeliTech is our newest “Incubaby” designed to create a global ecosystem to accelerate psychedelic innovation by investing in research, education and clinical trials. Here’s the press release we received this morning. 2019 was an exciting year at iCAN.

CBD Oil’s Wide Availablity Challenges Medical Research

Puff Puff Post

Workers at clinics that treat addiction can do these studies and report the results. Sinai hospital performed clinical trials that used CBD to treat opiate addiction in both animal and human subjects. NYU is performing clinical trials on using CBD oil to treat alcohol abuse.

Urge Kentucky Lawmakers to Support Medical Cannabis Reform Today!

NORML

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013.

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). Our results need to be replicated in larger studies and clinical trials.